Literature DB >> 34264368

[Preoperative diagnostics in periampullary adenocarcinomas].

Ulrich Friedrich Wellner1, Louisa Bolm1, Miljana Vladimirov2, Tobias Keck3.   

Abstract

BACKGROUND: Approximately 30-40% of pancreatoduodenectomies for adenocarcinomas result in nonpancreatic periampullary adenocarcinoma as the final diagnosis. Depending on the origin, a distinction is made between four different carcinomas with histomorphological subtypes.
OBJECTIVE: Carcinoma location and subtype are of prognostic and therapeutic relevance; however, the preoperative differentiation is often incorrect despite modern diagnostics.
MATERIAL AND METHODS: Overview of the current literature on the classification and preoperative diagnostics of periampullary adenocarcinomas.
RESULTS: A precise knowledge of the papillary anatomy is necessary for the correct classification of diagnostic findings. Current studies demonstrate diagnostically valuable information from the anamnesis, imaging and endoscopy.
CONCLUSION: In ca. 70-80% of cases a correct diagnosis of the type of periampullary adenocarcinoma is possible on the basis of interdisciplinary diagnostics. This potentially enables a correspondingly individualized treatment planning in the preoperative phase.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Ampullary carcinoma; Distal cholangiocarcinoma; Duodenal carcinoma; Pancreatic head carcinoma; Pancreatoduodenectomy

Mesh:

Year:  2021        PMID: 34264368     DOI: 10.1007/s00104-021-01452-3

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  18 in total

1.  Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort study.

Authors:  Louisa Bolm; Kristina Ohrner; Gennaro Nappo; Felix Rückert; Carolin Zimmermann; Bettina M Rau; Ekaterina Petrova; Kim C Honselmann; Hryhoriy Lapshyn; Dirk Bausch; Jürgen Weitz; Marta Sandini; Tobias Keck; Alessandro Zerbi; Marius Distler; Ulrich F Wellner
Journal:  Pancreatology       Date:  2020-01-21       Impact factor: 3.996

2.  Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model.

Authors:  René Adam; Laurence Chiche; Thomas Aloia; Dominique Elias; Rémy Salmon; Michel Rivoire; Daniel Jaeck; Jean Saric; Yves Patrice Le Treut; Jacques Belghiti; Georges Mantion; Gilles Mentha
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

3.  Robotic-assisted laparoscopic tumor enucleation is a feasible technique for renal hilar tumors: A retrospective study.

Authors:  Tianyao Liu; Zihan Zhao; Baofu Feng; Xin Wang; Tianhang Li; Shangxun Xie; Wenjie Zhu; Xiaogong Li; Hongqian Guo; Rong Yang
Journal:  J Surg Oncol       Date:  2021-04-09       Impact factor: 3.454

4.  Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis.

Authors:  Mechteld C de Jong; Susan Tsai; John L Cameron; Christopher L Wolfgang; Kenzo Hirose; Mark G van Vledder; Frederic Eckhauser; Joseph M Herman; Barish H Edil; Michael A Choti; Richard D Schulick; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2010-09-01       Impact factor: 3.454

5.  International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.

Authors:  Shuji Isaji; Shugo Mizuno; John A Windsor; Claudio Bassi; Carlos Fernández-Del Castillo; Thilo Hackert; Aoi Hayasaki; Matthew H G Katz; Sun-Whe Kim; Masashi Kishiwada; Hirohisa Kitagawa; Christoph W Michalski; Christopher L Wolfgang
Journal:  Pancreatology       Date:  2017-11-22       Impact factor: 3.996

6.  The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.

Authors:  Daphne C Ang; Jinru Shia; Laura H Tang; Nora Katabi; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2014-10       Impact factor: 6.394

7.  Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).

Authors:  Maximilian Bockhorn; Faik G Uzunoglu; Mustapha Adham; Clem Imrie; Miroslav Milicevic; Aken A Sandberg; Horacio J Asbun; Claudio Bassi; Markus Büchler; Richard M Charnley; Kevin Conlon; Laureano Fernandez Cruz; Christos Dervenis; Abe Fingerhutt; Helmut Friess; Dirk J Gouma; Werner Hartwig; Keith D Lillemoe; Marco Montorsi; John P Neoptolemos; Shailesh V Shrikhande; Kyoichi Takaori; William Traverso; Yogesh K Vashist; Charles Vollmer; Charles J Yeo; Jakob R Izbicki
Journal:  Surgery       Date:  2014-02-07       Impact factor: 3.982

8.  Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.

Authors:  Peter Bronsert; Ilona Kohler; Martin Werner; Frank Makowiec; Simon Kuesters; Jens Hoeppner; Ulrich Theodor Hopt; Tobias Keck; Dirk Bausch; Ulrich Friedrich Wellner
Journal:  BMC Cancer       Date:  2013-09-22       Impact factor: 4.430

9.  When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery.

Authors:  Horacio J Asbun; Kevin Conlon; Laureano Fernandez-Cruz; Helmut Friess; Shailesh V Shrikhande; Mustapha Adham; Claudio Bassi; Maximilian Bockhorn; Markus Büchler; Richard M Charnley; Christos Dervenis; Abe Fingerhutt; Dirk J Gouma; Werner Hartwig; Clem Imrie; Jakob R Izbicki; Keith D Lillemoe; Miroslav Milicevic; Marco Montorsi; John P Neoptolemos; Aken A Sandberg; Michael Sarr; Charles Vollmer; Charles J Yeo; L William Traverso
Journal:  Surgery       Date:  2014-01-02       Impact factor: 3.982

10.  Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients-Proposal of a New Simplified Borderline Resectability Definition.

Authors:  Louisa Bolm; Katharina Mueller; Katharina May; Stefan Sondermann; Ekaterina Petrova; Hryhoriy Lapshyn; Kim Christin Honselmann; Dirk Bausch; Sergii Zemskov; Peter Bronsert; Tobias Keck; Steffen Deichmann; Ulrich F Wellner
Journal:  Cancers (Basel)       Date:  2020-04-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.